J. Jang

发表

The differential proteome profile of stomach cancer: identification of the biomarker candidates.

W. Ha, Woo S Ha, J. Jang, 2004, Oncology research.

A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer

Dong-Wan Kim, Sang-We Kim, Heung Tae Kim, 2020, British Journal of Cancer.

Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients

S. Kang, S. Oh, Hyun Joo Kim, 2017, Supportive Care in Cancer.

A phase II study of leucovorin, 5-FU and docetaxel combination chemotherapy in patients with inoperable or postoperative relapsed gastric cancer.

J. Jang, K. Lee, Hank Lee, 2008, Cancer research and treatment : official journal of Korean Cancer Association.

Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer

B. Cho, H. Song, Hoon-Kyo Kim, 2017, Cancer Chemotherapy and Pharmacology.

Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies

S. Park, I. Hwang, Byeong-Bae Park, 2012, Cancer research and treatment : official journal of Korean Cancer Association.

Proteomic analysis revealed a strong association of a high level of α1‐antitrypsin in gastric juice with gastric cancer

D. Lim, J. Jang, O. Lee, 2004, Proteomics.

Natural history of metastatic biliary tract cancer (BTC) patients with good performance status (PS) who were treated with only best supportive care (BSC).

Joon-Oh Park, S. Park, I. Hwang, 2015, Japanese journal of clinical oncology.

Obstructive sleep apnea in airline pilots during daytime sleep following overnight flights

Su-Hyun Han, J. Jang, Gun-Young Lee, 2021, Journal of sleep research.

The Expression of Thymidine Phosphorylase in Cancer-infiltrating Inflammatory Cells in Stomach Cancer

W. Ha, J. Jang, Hwal-Woong Kim, 2007, Journal of Korean medical science.

Anti-carcinogenic actions of glycoprotein conjugated with isoflavones from submerged-liquid culture of Agaricus blazei mycelia through reciprocal expression of Bcl-2 and Bax proteins

S. Kim, G. Kim, Young-S. Kim, 2014 .

Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study

S. Kang, I. Hwang, Eun Mi Nam, 2018, Cancer communications.

Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial

Myung Ah Lee, J. Byun, S. Oh, 2010, Cancer Chemotherapy and Pharmacology.

Phase II study of mFOLFOX3 (5-fluorouracil, leucovorin, oxaliplatin) as second-line treatment after gemcitabine failure in patients with unresectable/metastatic biliary tract cancer

Joon-Oh Park, I. Hwang, S. Oh, 2015, Cancer Chemotherapy and Pharmacology.

Treatment outcomes of gemcitabine alone versus gemcitabine plus platinum for advanced biliary tract cancer: a Korean Cancer Study Group retrospective analysis

Myung Ah Lee, H. Song, I. Hwang, 2014, Cancer Chemotherapy and Pharmacology.

Preventive effect of t,t-conjugated linoleic acid on 12-O-tetradecanoylphorbol-13-acetate-induced inhibition of gap junctional intercellular communication in human mammary epithelial MCF-10A cells.

J. Jang, M. Rakib, Y. S. Kim, 2011, Journal of agricultural and food chemistry.

C linical Significance of the L evels of Serum C holesterol in P atients w ith G astric C ancer

Tae Hyo Kim, W. Jung, J. Jang, 2003 .

Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3).

I. Hwang, S. Sym, S. Oh, 2021, European journal of cancer.

A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01).

Sung-Bae Kim, M. Ahn, Keunchil Park, 2012, European journal of cancer.

Isolation of Anticarcinogenic Isoflavone-conjugated Glycoproteins from a Submerged Liquid Culture of Agaricus blazei Mycelia by the Autolysis Process

S. Kim, G. Kim, Young-S. Kim, 2014 .

Posttranslational regulation of the retinoblastoma gene family member p107 by calpain protease

Yung-Hyun Choi, Sang-Gu Hwang, P. Nguyen, 1999, Oncogene.

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.

Myung Ah Lee, Joon-Oh Park, S. Park, 2012, The Lancet. Oncology.

Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive‐stage disease small cell lung cancer: Results from a randomized controlled trial

S. Hahn, Dong-Wan Kim, D. Heo, 2019, Thoracic cancer.

Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer

S. Hahn, Keunchil Park, Dong-Wan Kim, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer.

Joon-Oh Park, J. Ahn, M. Ahn, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of docetaxel and ifosfamide for patients with platinum-resistant or refractory non-small cell lung cancer in a salvage setting.

Seok-Hyun Kim, Gyeong-Won Lee, J. Jang, 2004, Cancer research and treatment : official journal of Korean Cancer Association.

Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects

Keunchil Park, Jeeyun Lee, I. Hwang, 2015, Supportive Care in Cancer.

A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01)

M. Ahn, Dong-Wan Kim, B. Cho, 2016, Oncotarget.

A Mobile Game for Patients With Breast Cancer for Chemotherapy Self-Management and Quality-of-Life Improvement: Randomized Controlled Trial

Young In Kim, Doug Hyun Han, D. Han, 2018, Journal of medical Internet research.

Triplet cytotoxic chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced pancreatic cancer.

H. Song, K. Lee, J. Jang, 2015, Oncology letters.

T He Differential G Ene Expression Profiles Betw Een Sensitive and Resistant Breast C Ancer C Ells to a Driam Ycin by Cdn a M Icroarray

M. Ahn, Junghye Choi, J. Jang, 2010 .

The differential gene expression profiles between sensitive and resistant breast cancer cells to adriamycin by cDNA microarray.

M. Ahn, Junghye Choi, J. Jang, 2004, Cancer research and treatment : official journal of Korean Cancer Association.

Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.

J. Ahn, Sang-We Kim, Jin-Hyoung Kang, 2015, The oncologist.

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)

Y. Min, S. Kim, Jin Seok Kim, 2012, Journal of Hematology & Oncology.

Gastric leptomeningeal carcinomatosis: multi-center retrospective analysis of 54 cases.

I. Hwang, Hyo-jin Kim, Jeeyun Lee, 2009, World journal of gastroenterology.

Dynamic Control of Oligosaccharide Modification in the Mammary Gland: Linking Recombinant Human Erythropoietin

H. Seo, Hyuk Song, Jin-Hoi Kim, 2006, Transgenic Research.

Occurrence of colonic liposarcoma after retroperitoneal liposarcoma

I. Hwang, J. Jang, J. Choi, 2014, The Korean journal of internal medicine.

A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor‐Induced Skin Toxicities

Young Saing Kim, M. Roh, I. Hwang, 2019, The oncologist.

Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III Trial.

E. Bruera, I. Hwang, Haa-Na Song, 2017, The oncologist.

Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis

Joon-Oh Park, Young Saing Kim, I. Hwang, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy

I. Hwang, C. Choi, Song-Ee Park, 2018, Medicine.

Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness

C. Jeong, Soon-Chan Hong, I. Hwang, 2011, Investigational New Drugs.

The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas

Young Saing Kim, I. Hwang, Haa-Na Song, 2016, Cancer Chemotherapy and Pharmacology.

Interference with daily functioning by breakthrough pain in patients with cancer

S. Koh, Ho-Suk Oh, M. Lee, 2020, Supportive Care in Cancer.

Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types

Y. L. Sung, Myung Ah Lee, M. Ahn, 2017, Supportive Care in Cancer.

A phase II trial of haptaplatin/5-FU and leucovorin for advanced stomach cancer.

Young-Joon Lee, W. Ha, Gyeong-Won Lee, 2005, Cancer research and treatment : official journal of Korean Cancer Association.

A Phase II T rial of H aptaplatin / 5-FU and Leucovorin for A dvanced Stom ach C ancer

Young-Joon Lee, W. Ha, Gyeong-Won Lee, 2009 .

A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer

I. Hwang, S. Oh, H. Kwon, 2012, Investigational New Drugs.

Serum biomarkers for predicting overall survival and early mortality in older patients with metastatic solid tumors.

J. W. Kim, I. Hwang, H. J. Kim, 2019, Journal of geriatric oncology.

Incidence, Risk Factors, and Clinical Outcomes of Acute Kidney Injury Caused by Palliative Chemotherapy in Lung Cancer

Heejin Kim, I. Hwang, Su-Hyun Kim, 2019, Journal of Cancer.

Differential inhibitory effects of conjugated linoleic acid isomers on mouse forestomach neoplasia induced by benzo(a)pyrene.

G. Kim, T. Oh, J. Jang, 2010, Journal of agricultural and food chemistry.

Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial.

S. Oh, J. Lee, M. Lee, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparative analysis between combination and single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer: A nationwide population-based outcome study.

Soyeon Ahn, Y. J. Kim, J. Kim, 2018, Lung cancer.

Totality outcome of afatinib sequential treatment in patients with EGFR mutation-positive non-small cell lung cancer in South Korea (TOAST): Korean Cancer Study Group (KCSG) LU-19-22

Keunchil Park, Y. Min, K. Lee, 2021, Translational Lung Cancer Research.

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locoregional Esophageal Cancer.

J. Kang, I. Hwang, Seok-Hyun Kim, 2001, Cancer research and treatment : official journal of Korean Cancer Association.

A Mobile Game for Patients With Breast Cancer for Chemotherapy Self-Management and Quality-of-Life Improvement: Randomized Controlled Trial

D. Han, Heejin Kim, S. Kim, 2018, Journal of medical Internet research.

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locoregional Esophageal Cancer.

I. Hwang, Seok-Hyun Kim, W. Jung, 2001, Cancer research and treatment : official journal of Korean Cancer Association.

1339PDPHASE II TRIAL OF EPIDERMAL GROWTH FACTOR OINTMENT FOR PATIENTS WITH ERLOTINIB-RELATED SKIN EFFECTS.

I. Hwang, Hyo-jin Kim, H. Kim, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.